Related Experiment Videos
Monoclonal antibodies in oncology
Summary
Monoclonal antibodies (MCAs) offer powerful diagnostic tools by distinguishing normal from cancer cells. This technology aids in classifying cancers, detecting tumor markers, and localizing tumors, paving the way for targeted therapies.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- Monoclonal antibodies (MCAs) offer potential for differentiating normal and neoplastic cells.
- Human tumor antigens are crucial targets for diagnostic and therapeutic applications.
- The review examines the evidence supporting the role of tumor antigens.
Purpose of the Study:
- To review the evidence for human tumor antigens.
- To highlight the diagnostic and therapeutic applications of monoclonal antibody technology in oncology.
Main Methods:
- Review of existing scientific evidence on human tumor antigens.
- Application of monoclonal antibody technology in various diagnostic fields.
Main Results:
- Monoclonal antibodies are beneficial in immunohistology for complex diagnostic challenges.
- MCAs enable new classifications of lymphoma and leukemia based on surface molecules.
- Detection of shed tumor antigens is a routine assessment for solid tumors.
- Isotopically labeled MCAs are used for localizing primary and metastatic tumors.
Conclusions:
- Monoclonal antibody technology is currently benefiting several diagnostic areas.
- The use of MCAs is a promising diagnostic tool and a precursor to therapeutic applications.
- Clinical trials are underway to arm antibodies for therapeutic purposes.